Ensign Peak Advisors
IMMU

Ensign Peak Advisors’s Immunomedics Inc IMMU Stock Holding History

Ensign Peak Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-256,753
Closed -$21.8M – 1905
2020
Q3 		$21.8M Buy
256,753
+25,004
+11% +$1.26M 0.06% 289
2020
Q2 		$8.21M Buy
+231,749
New +$6.78M 0.02% 470

Ensign Peak Advisors's IMMU Position: Q4 2020 in Review

Ensign Peak Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 256,753 shares — an estimated $21.8M sold.

Ensign Peak Advisors first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $21.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Ensign Peak Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Ensign Peak Advisors sold 256,753 Immunomedics Inc shares in Q4 2020, an estimated $21.8M.
  • Ensign Peak Advisors first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Ensign Peak Advisors's Immunomedics Inc position peaked at $21.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Ensign Peak Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.